Biocardia, Inc. (BCDA) — 8-K Filings

8-K Filings (50)

• 8-K Filing — May 8, 2026
• BioCardia Files 8-K on April 28, 2026 — Apr 28, 2026 Risk: low
  BioCardia, Inc. filed an 8-K on April 28, 2026, reporting other events and financial statements/exhibits. The filing details include the company's mailing and b
• 8-K Filing — Apr 20, 2026
• 8-K Filing — Apr 2, 2026
• BioCardia Files 8-K on Financial Results; Investors Await Details — Mar 24, 2026
  BioCardia, Inc. filed an 8-K on March 24, 2026, reporting under Item 2.02, "Results of Operations and Financial Condition." This indicates the company has relea
• BioCardia Files 8-K Report — Dec 16, 2025 Risk: low
  On December 16, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No specifi
• 8-K Filing — Dec 3, 2025
• BioCardia Files 8-K: Other Events & Financials — Nov 24, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on November 24, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is bas
• 8-K Filing — Nov 10, 2025
• BioCardia Files 8-K: Financial Statements & Exhibits — Oct 30, 2025 Risk: low
  On October 30, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclo
• BioCardia Files 8-K on Shareholder Nominations — Oct 7, 2025 Risk: medium
  On October 7, 2025, BioCardia, Inc. filed an 8-K report detailing shareholder nominations for its board of directors. The filing indicates that the company is a
• BioCardia, Inc. Files 8-K Report — Oct 2, 2025 Risk: low
  On October 2, 2025, BioCardia, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 320 Soquel Way, Sunnyvale
• BioCardia Faces Delisting Concerns — Sep 24, 2025 Risk: high
  BioCardia, Inc. filed an 8-K on September 24, 2025, to report a notice of delisting or failure to meet continued listing standards. The company is based in Sunn
• BioCardia Files 8-K — Sep 22, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on September 22, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is in
• BioCardia Files 8-K: Other Events & Financials — Sep 19, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on September 19, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is in
• BioCardia Files 8-K: Reg FD Disclosure & Financials — Sep 18, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on September 18, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as T
• BioCardia Files 8-K: Other Events & Financials — Aug 13, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on August 13, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is incor
• BioCardia, Inc. Files 8-K on Financials — Aug 11, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on August 11, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and ex
• BioCardia Files 8-K: Other Events & Financials — Aug 4, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on August 4, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is incorp
• BioCardia Files 8-K — Jul 24, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on July 24, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is incorpo
• BioCardia, Inc. Files 8-K Report — Jul 16, 2025 Risk: low
  On July 16, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material e
• BioCardia Files 8-K on Equity Sales and Other Events — Jul 2, 2025 Risk: medium
  On June 30, 2025, BioCardia, Inc. filed an 8-K report detailing unregistered sales of equity securities. The company also reported other events and filed financ
• BioCardia Files 8-K Report — Jun 25, 2025 Risk: low
  On June 25, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific new fin
• BioCardia, Inc. Files 8-K Report — May 6, 2025 Risk: low
  On May 6, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial
• BioCardia Files 8-K: Regulation FD & Financials — May 1, 2025 Risk: low
  On April 30, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No specific m
• BioCardia Files 8-K on Equity Sales and Other Events — Apr 23, 2025 Risk: medium
  On April 22, 2025, BioCardia, Inc. filed an 8-K report detailing unregistered sales of equity securities. The company also reported other events and filed finan
• BioCardia Files 8-K: Regulation FD & Exhibits — Apr 15, 2025 Risk: low
  On April 15, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specifi
• BioCardia Files 8-K: Other Events & Financials — Apr 11, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on April 11, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is incorp
• BioCardia Faces Delisting Concerns — Apr 4, 2025 Risk: high
  BioCardia, Inc. filed an 8-K on April 4, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of April 1, 2025. T
• BioCardia Files 8-K: Regulation FD, Other Events, Financials — Mar 31, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on March 31, 2025, reporting on events that occurred on the same date. The filing includes information related to Regulation FD Dis
• BioCardia Files 8-K — Mar 10, 2025 Risk: low
  BioCardia, Inc. filed an 8-K on March 10, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., Cardo Med
• BioCardia, Inc. Files 8-K Report — Feb 27, 2025 Risk: low
  On February 27, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific materi
• BioCardia Files 8-K Report — Feb 13, 2025 Risk: low
  On February 13, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific new
• BioCardia Files 8-K Report — Jan 27, 2025 Risk: low
  On January 27, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific fina
• BioCardia Files Routine 8-K with Financials — Dec 17, 2024 Risk: low
  On December 17, 2024, BioCardia, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update rather t
• BioCardia Files 8-K: Other Events & Financials — Dec 4, 2024 Risk: low
  BioCardia, Inc. filed an 8-K on December 4, 2024, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is inco
• BioCardia Files 8-K: Other Events & Financials — Oct 28, 2024 Risk: low
  BioCardia, Inc. filed an 8-K on October 28, 2024, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is inco
• BioCardia Files 8-K — Sep 18, 2024 Risk: low
  BioCardia, Inc. filed an 8-K on September 18, 2024, to report other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is in
• BioCardia Files 8-K: Other Events & Financials — Sep 9, 2024 Risk: low
  BioCardia, Inc. filed an 8-K on September 9, 2024, reporting on other events and financial statements. The filing indicates a report date of September 3, 2024,
• BioCardia Files 8-K: Other Events & Financials — Sep 3, 2024 Risk: low
  BioCardia, Inc. filed an 8-K on August 29, 2024, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is incor
• BioCardia Files 8-K: Regulation FD & Financials — Aug 30, 2024 Risk: low
  BioCardia, Inc. filed an 8-K on August 30, 2024, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as
• BioCardia Files 8-K: Other Events Reported — Aug 28, 2024 Risk: medium
  BioCardia, Inc. filed an 8-K on August 28, 2024, to report other events. The filing does not contain specific details about the nature of these events, dollar a
• BioCardia Files 8-K: Regulation FD & Exhibits — Aug 21, 2024 Risk: low
  BioCardia, Inc. filed an 8-K on August 21, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specifi
• BioCardia Files 8-K: Other Events & Exhibits Noted — Jul 30, 2024 Risk: low
  On July 30, 2024, BioCardia, Inc. filed an 8-K report detailing "Other Events" and "Financial Statements and Exhibits." The filing does not disclose specific fi
• BioCardia Files 8-K: Regulation FD & Financials — Jul 25, 2024 Risk: low
  On July 25, 2024, BioCardia, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company
• BioCardia Closes $10M Public Offering — Jul 17, 2024 Risk: medium
  On July 17, 2024, BioCardia, Inc. filed an 8-K report detailing the closing of its previously announced underwritten public offering. The company successfully r
• BioCardia, Inc. Files 8-K Report — Jul 8, 2024 Risk: low
  On July 8, 2024, BioCardia, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company,
• BioCardia, Inc. Files 8-K Report — Jun 10, 2024 Risk: low
  On June 10, 2024, BioCardia, Inc. filed an 8-K report. The filing indicates that the company's principal executive offices are located at 320 Soquel Way, Sunnyv
• BioCardia Files 8-K: Other Events & Exhibits — Jun 7, 2024 Risk: low
  BioCardia, Inc. filed an 8-K on June 7, 2024, reporting an "Other Events" and "Financial Statements and Exhibits" filing. The company, formerly known as Tiger X
• BioCardia Files 8-K on Security Holder Rights & Bylaws — May 30, 2024 Risk: medium
  BioCardia, Inc. filed an 8-K on May 29, 2024, reporting material modifications to the rights of its security holders and amendments to its articles of incorpora

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX